PPG Industries Tests Laser Cured Powder Coatings For Efficiency And Growth

by
Industrial powder coating application line with laser curing system in operation at manufacturing facility

**” PPG Industries has launched pilot testing of revolutionary laser-based curing technology for powder coatings through a strategic collaboration with IPG Photonics and Whirlpool Corporation. The initiative features IPG’s PhotoniCURE™ system installed at PPG’s Strongsville, Ohio facility, aiming to slash energy consumption, cut curing times dramatically, lower costs, and reduce environmental impact while boosting production … Read more

Claritas iPET™ Gains Australian TGA Approval for Advanced PET Image Processing Software

by
Advanced PET scan image processing software interface showing enhanced diagnostic quality from low-dose or short-time acquisition.

Claritas iPET™, an innovative medical software device from Claritas HealthTech, has secured approval from Australia’s Therapeutic Goods Administration (TGA) to supply its image processing technology. This clearance enables hospitals and imaging centers in Australia to utilize the software for enhancing Positron Emission Tomography (PET) scans, including those combined with CT or MRI. The tool delivers … Read more

China Sets Lowest Economic Growth Target Since 1991

by
Chart showing China's declining GDP growth targets over decades, highlighting the 2026 range of 4.5-5% as the lowest since 1991.

China has officially set its GDP growth target for 2026 at 4.5% to 5%, marking the most modest goal since 1991 and the first downgrade below 5% in over three decades. This pragmatic shift acknowledges persistent domestic challenges like a prolonged property slump, weak consumption, deflationary pressures, and external headwinds including U.S. trade tensions. While … Read more

BankUnited (BKU) Price Target Boosted to $56 by Cantor Fitzgerald Amid Strong Momentum

by
BankUnited headquarters building exterior with modern architecture and company signage

Cantor Fitzgerald has increased its price target on BankUnited shares from $51 to $56 while maintaining an Overweight rating, signaling continued confidence in the regional bank’s performance. The adjustment comes as BKU trades around $47, reflecting solid net interest margin expansion, core loan growth, and shareholder-friendly capital returns following a strong 2025 financial year. This … Read more

Pillar To Post Home Inspectors Celebrates Banner Year and System-Wide Momentum at 2026 Brand Conference

by
Group of professional home inspectors and franchise owners networking at the Pillar To Post 2026 Brand Conference in St. Louis.

“Pillar To Post Home Inspectors marked a standout year of achievement and growth during its 2026 Brand Conference in St. Louis, highlighting record performance, franchise momentum, ongoing industry leadership, and strategic innovations poised to drive continued success across North America’s largest home inspection network.” Pillar To Post Home Inspectors Celebrates Banner Year and System-Wide Momentum … Read more

U.S. GoldMining Delivers Robust Preliminary Economic Assessment for Alaska’s Whistler Gold-Copper Project

by
Open-pit gold-copper mining operation in Alaska landscape with heavy machinery and mountainous terrain

U.S. GoldMining Inc. has released a highly positive preliminary economic assessment for its flagship Whistler Gold-Copper Project in Alaska, highlighting strong economics with an after-tax NPV of $2.04 billion, 33% IRR, and a quick 2.1-year payback at base case metal prices. The study outlines a 14.6-year open-pit mine producing 3.6 million ounces of gold equivalent … Read more

ORIC Pharmaceuticals Teases Key 2026 Catalysts, Phase 3 Plans for Prostate and Lung Cancer Drugs

by
ORIC Pharmaceuticals laboratory researchers analyzing oncology data for prostate and lung cancer drug development

“ORIC Pharmaceuticals is positioning two lead candidates for major late-stage advancement in 2026, with rinzimetostat (formerly ORIC-944) set to enter its first global Phase 3 trial in metastatic castration-resistant prostate cancer in the first half of the year, and enozertinib (ORIC-114) advancing toward registrational trials in first-line non-small cell lung cancer. The company anticipates multiple … Read more

Barclays Cuts Price Target on ACV Auctions Amid Cautious Outlook

by
Stock chart and Barclays logo overlay on ACV Auctions ticker symbol ACVA with downward arrow indicating price target cut

Barclays has lowered its price target on ACV Auctions (NYSE: ACVA) from $8 to $7 while maintaining a Hold rating, reflecting tempered expectations following the company’s recent Q4 earnings report. The adjustment highlights concerns over profitability challenges, guidance alignment, and ongoing market pressures in the wholesale used vehicle sector, despite solid revenue performance and strategic … Read more

MaxLinear (MXL) Valuation After Recent Share Price Weakness

by
Chart showing MaxLinear (MXL) stock price trend with recent weakness and valuation metrics overlay

MaxLinear’s shares have faced pressure lately, trading around $17.43 after dipping from recent highs near $20.82. Despite the pullback, the company’s strong Q4 2025 results—with revenue up 48% year-over-year—and optimistic guidance for infrastructure-driven growth in 2026, including $100-130 million from Keystone PAM4 DSPs, suggest the current valuation may offer an attractive entry point for long-term … Read more

FIGS Q4 Earnings Call Highlights: Record Revenue Surge and Strong Momentum into 2026

by
FIGS Inc. corporate logo on a financial earnings report background with upward stock chart elements

FIGS delivered a standout fourth quarter for fiscal 2025, with net revenue soaring 33% year-over-year to a record $201.9 million, surpassing expectations significantly. The company achieved robust profitability improvements, including a net income margin of 9.2% and adjusted EBITDA margin of 13.2%. Active customers reached an all-time high of over 2.9 million, up 9%, while … Read more